LINGYE
Dead / Abandoned — Abandoned — failure to respond (as of 27 Mar 2023)
What this means for you
This application is over — abandoned 10 Mar 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97284409
- Mark type
- Stylized text
- Filed
- 25 Feb 2022
- Abandoned
- 10 Mar 2023
- Attorney of record
- Lawrence E. Apolzon
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of infectious diseases, immune system diseases and disorders, pain, allergy inflammation, alopecia, tumors, respiratory diseases, blood diseases and disorders, cognitive disorders, cardiovascular disease, blood vasculare disease, gynecological diseases, hyperproliferative disease, skin diseases, obesity, and endocrine disease; Pharmaceutical preparations and substances for the treatment of infectious diseases, immune system diseases and disorders, pain, allergy inflammation, alopecia, tumors, respiratory diseases, blood diseases and disorders, cognitive disorders, cardiovascular disease, blood vasculare disease, gynecological diseases, hyperproliferative disease, skin diseases, obesity, and endocrine disease; Drug delivery agents in the form of powders, tablets, capsules, injectable pharmaceuticals, pills, caplets, liquid drops, sachets, spray, ointment, cream, foam gel, lotion, patch, inhaler, granule, film, suspension, infusion and suppository that provide controlled release of the active ingredients for a wide variety of pharmaceuticals
- Class 042 — Scientific and technological services: Research and development of new products for others; Scientific research; Chemical analysis; Chemical research; Biological research; Cosmetic research; Medical research; Development of pharmaceutical preparations and medicines; Scientific research in the nature of conducting clinical trials for others; Inspection of medical equipment for quality control purposes; Chemical engineering; Technology consultation in the field of medical research; Research and development of technology in the field of medical research
Owner
- Hangzhou SoliPharma Co., Ltd., Hangzhou, Zhejiang, CN
Prosecution history
- 27 Mar 2023 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 27 Mar 2023 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 27 Mar 2023 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 09 Dec 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 09 Dec 2022 — NON-FINAL ACTION E-MAILED
- 09 Dec 2022 — NON-FINAL ACTION WRITTEN
- 09 Dec 2022 — ASSIGNED TO EXAMINER
- 02 Mar 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 01 Mar 2022 — NEW APPLICATION ENTERED